BRCA1 and cancer: After the disclosure of the BRCA1/2 test result, using the MICRA questionnaire [16], BjØrnslett et al. [39] reported a higher level and a different hierarchy of needs prevalence in BRCA1/2 carriers compared to non-carriers (e.g., “frustrated that there are no definite cancer prevention guidelines for me”; 41%/ninth highest prevalent need, versus 38%/third highest prevalent need).